Categories AlphaGraphs, Earnings, Health Care

Abbott Laboratories ease past street targets: Infographic

Abbott Laboratories (NYSE: ABT) reported second-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q2 sales of $ 10.2 billion, up 40% year-over-year and higher than the Wall Street projection. Net income of $1.17 per share was also above the target that analysts had anticipated.

ABT shares rose 0.4% immediately following the announcement. The stock has gained 9% since the beginning of this year.

Abbott Laboratories Q2 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Abbott Laboratories Q2 earnings call transcript

Prior performance

  • ABBOTT REPORTS THIRD-QUARTER 2020 RESULTS; ACHIEVES STRONG DOUBLE-DIGIT EARNINGS GROWTH AND RAISES GUIDANCE
  • Abbott Laboratories Q2 2020 earnings infographic

Most Popular

Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line

Macy’s (M): A few points to consider if you have an eye on this retailer

Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top